ScholarIQanswers from OpenAlex

Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion

PaperCitations, authors & open-access status

Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion have?

ScholarIQcitation count

Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion has 124 citations in the OpenAlex counts ScholarIQ stores.

When was Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion published?

ScholarIQyear

Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion has 2015 year in the ScholarIQ index.

What is the open-access status of Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion?

ScholarIQoa status

Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion has green oa status in the ScholarIQ index.

What is the DOI of Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion?

ScholarIQdoi

The DOI for Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion is on the source record.

What is the PMID of Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion?

ScholarIQpmid

The PMID for Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion is on the source record.

What is the OpenAlex record for Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion?

ScholarIQopenalex

The OpenAlex for Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial